Patents by Inventor Frederik Beck

Frederik Beck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Polymorphs Of The Potassium Salt Of Atorvastatin
    Publication number: 20080033032
    Abstract: Novel polymorphs Forms I, II and III of the potassium salt of Atorvastatin, (?R,?R)-2-(p-fluorophenyl)-?, ?-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid, are obtained directly by precipitation of the potassium salt of Atorvastatin with ethanol (polymorph I), with 1-propanol (polymorph II) and by recrystallisation of polymorph I from 2-propanol (polymorph III).
    Type: Application
    Filed: August 26, 2005
    Publication date: February 7, 2008
    Applicant: Sandoz A/S
    Inventors: Frederik Beck, Erik Fischer
  • Modified peptide nucleic acid (PNA) molecules
    Publication number: 20030199431
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria.
    Type: Application
    Filed: March 27, 2002
    Publication date: October 23, 2003
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Modified peptide nucleic acid (PNA) molecules
    Publication number: 20030176325
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria.
    Type: Application
    Filed: October 19, 2001
    Publication date: September 18, 2003
    Applicant: Pantheco A/S and Peter E. Nielsen
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Modified peptide nucleic acid (PNA) molecules
    Patent number: 6548651
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria. More specifically, the invention relates to peptide nucleic acid (PNA) sequences that are modified by conjugating cationic peptides to the PNA moiety in order to obtain novel PNA molecules that exhibit enhanced anti-infective properties.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: April 15, 2003
    Assignees: Pantheco A/S
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman